Brief: Castle Biosciences Q3 Net Income USD 2.269 Million Vs. IBES Estimate USD -100.9 Thousand
04/11/2024 21:05
Nov 04 (Reuters) - Castle Biosciences Q3 operating income USD 5.079 million. * Q3 revenue USD 85.782 million vs. IBES estimate USD 79.8 million * Q3 operating expenses USD 80.703 million * Q3 pretax profit USD 8.282 million vs. IBES estimate USD 84.4 thousand
Recent news on Castle Biosciences
See all newsBrief: Castle Biosciences, - Opens New Laboratory And Office Facility In Scottsdale, Arizona
U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Castle Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Castle Biosciences beats Q2 revenue estimates, hikes forecast
Brief: Castle Biosciences Q2 Revenue USD 103.546 Million Vs. IBES Estimate USD 86.2 Million